D-0148-2021 Class II Terminated
FDA drug recall D-0148-2021 was initiated by Biogen MA Inc. on Dec 9, 2020 and is designated Class II. Reason for recall: Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing. The recall status is terminated (terminated Sep 17, 2021). Affected quantity: 5,307 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 23, 2020
- Initiation Date
- Dec 9, 2020
- Termination Date
- Sep 17, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,307 bottles
Product description
Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01
Reason for recall
Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.
Distribution pattern
USA Nationwide
Code information
Lot #: a) 101801, Exp 5/31/2021; 102826, Exp 6/21/2021; b) 101799, Exp 5/31/2021; 102362, Exp 6/21/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0148-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026